Growth Metrics

Enovis (ENOV) Net Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -32.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -87.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 42.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -87.88%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -48.90%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 129.29%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -65.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 33.47%
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn -8.70%

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 -8.70%
Dec 31, 2025 27.73%
Oct 3, 2025 36.29%
Jul 4, 2025 26.15%
Apr 4, 2025 43.45%
Dec 31, 2024 -73.26%
Sep 27, 2024 -26.89%
Jun 28, 2024 64.63%
Mar 29, 2024 -64.17%
Dec 31, 2023 -28.06%
Sep 29, 2023 -30.36%
Jun 30, 2023 26.73%
Mar 31, 2023 -26.19%
Dec 31, 2022 19.08%
Sep 30, 2022 9.36%
Jul 1, 2022 -235.95%
Apr 1, 2022 -143.77%
Dec 31, 2021 149.16%
Oct 1, 2021 46.62%
Jul 2, 2021 -271.54%
Apr 2, 2021 892.59%
Dec 31, 2020 60.14%
Oct 2, 2020 9.16%
Jul 3, 2020 -90.43%
Apr 3, 2020 153.07%
Dec 31, 2019 -56.21%
Sep 27, 2019 -164.20%
Jun 28, 2019 -10.40%
Mar 29, 2019 6.85%
Dec 31, 2018 -21.88%
Sep 28, 2018 1.83%
Jun 29, 2018 96.29%
Mar 30, 2018 26.16%
Dec 31, 2017 -37.53%
Sep 29, 2017 26.30%
Jun 30, 2017 33.82%
Mar 31, 2017 -28.28%
Dec 31, 2016 28.08%
Sep 30, 2016 -58.67%
Jul 1, 2016 -26.63%
Apr 1, 2016 72.27%
Dec 31, 2015 18.96%
Sep 25, 2015 51.54%
Jun 26, 2015 48.06%
Mar 27, 2015 -29.44%
Dec 31, 2014 14.84%
Sep 26, 2014 -117.69%
Jun 27, 2014 -120.69%
Mar 28, 2014 123.76%
Dec 31, 2013 -162.55%
Sep 27, 2013 56.43%